Adherence to immunosuppression medications among heart transplant recipients: Challenges, opportunities, and potential role of digital approaches in the covid-19 era

Tasmeen Hussain, Keira Nassetta, Sherif M. Badawy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Society and medical practice have been restructured dramatically to avoid further spread of the COVID-19 virus; telehealth/telemedicine, mask wearing, and nationwide social distancing practices have become widespread. However, we still face unprecedented challenges in fields where patients require frequent and active follow-up visits for monitoring, including that of solid-organ transplant, and in particular, heart transplant. Adherence to immunosuppression remains a unique challenge in heart transplantation, especially during the COVID-19 pandemic. Failure to adhere to immunosuppression can have disastrous consequences, including graft rejection and death. In this article, we discuss challenges related to adherence to immunosuppression medications among heart transplant recipients, as well as opportunities to leverage digital approaches and interventions to monitor and optimize adherence behavior and health outcomes in this population.

Original languageEnglish (US)
Article number68
JournalJournal of Cardiovascular Development and Disease
Volume8
Issue number6
DOIs
StatePublished - Jun 2021

Keywords

  • Adherence
  • Compliance
  • COVID
  • COVID-19
  • Digital
  • EHealth
  • Heart transplant
  • Immunosuppression
  • MHealth
  • Pandemic

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Adherence to immunosuppression medications among heart transplant recipients: Challenges, opportunities, and potential role of digital approaches in the covid-19 era'. Together they form a unique fingerprint.

Cite this